BusinessILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Key Milestones Including Positive Phase 1b Clinical Study DataBy Nasdaq OMXJul 5, 2017, 1:00 PM UTC
BusinessGreat Basin Scientific Receives FDA 510(k) Clearance for Bordetella Direct TestBy Nasdaq OMXApr 3, 2017, 8:00 PM UTC
BusinessGreat Basin Scientific Completes Clinical Trial, Submits FDA 510(k) Application for Bordetella Direct TestBy Nasdaq OMXFeb 1, 2017, 12:00 PM UTC
BusinessPhase 1b Clinical Trial of BPZE1 Pertussis Vaccine Completes Enrollment of Randomized Study GroupsBy Nasdaq OMXFeb 19, 2016, 2:55 PM UTC
